Skip to content

Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk

Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05268783
Acronym
Quali-NET
Enrollment
1000
Registered
2022-03-07
Start date
2018-11-05
Completion date
2029-12-31
Last updated
2022-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life

Keywords

neuroendocrine neoplasms

Brief summary

Neuroendocrine tumors (NET) are rare tumors that require specific diagnosis and treatment. Therefore, this poses a challenge for clinical practice. Diagnosis and treatment can be optimized when physician specialists and other healthcare providers, across various hospitals, join forces to provide patients the best care. Based on this idea, a hospital network called NETwerk was set up. The following hospitals are part of this network: University Hospital Antwerp, VITAZ, AZ Monica, AZ Voorkempen, AZ Klina, Gasthuiszusters Antwerpen, Ziekenhuis Netwerk Antwerpen and AZ Rivierenland. In this NETwerk, patients with a neuroendocrine tumor or patients suspected with a neuroendocrine tumor are discussed with the specialists and treated.The aim of this study is to map the quality of life of NET patients within NETwerk in order to optimize the quality of care. Throughout the diagnosis, the treatment process and the follow-up, the patient will be asked to fill out three questionnaires (QLQ-C30, QLQ-GI.NET21 and a satisfaction survey). These questionnaires will be filled out every six months at home. Patients will be asked to complete these questionnaires over a period of five years.

Interventions

PROCEDUREEORTC QLQ-C30

Quality of life questionnaire that has to be completed every 6 months

PROCEDUREEORTC QLQ-GI.NET21

Quality of life questionnaire that has to be completed every 6 months

Questionnaire regarding satisfaction of care that has to be completed on Day 1.

Sponsors

University Hospital, Antwerp
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* NEN patient * 18 years or older * Patient should appear in Oncobase

Exclusion criteria

* Patients who do not have an email address

Design outcomes

Primary

MeasureTime frameDescription
Quality of life measurement with QLQ-C30 questionnaire5 yearsQuality of life measurement with QLQ-C30 questionnaire
Quality of life measurement with QLQ-GI.NET21 questionnaire5 yearsQuality of life measurement with QLQ-GI.NET21 questionnaire

Secondary

MeasureTime frameDescription
Quality of care measurement with satisfaction survey5 yearsQuality of care measurement with satisfaction survey

Countries

Belgium

Contacts

Primary ContactTimon U Vandamme
timon.vandamme@uza.be03821
Backup ContactIsolde Van der Massen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026